Prescient Therapeutics Ltd
ASX:PTX ISIN:AU000000PTX3
Prescient Therapeutics Limited is a clinical-stage oncology company. The Company's principal activities include in-licensing of intellectual property; the preparation for and conduct of clinical trials relating to the Company's products; business development associated with the promotion of its technologies and products, and business development associated with developing collaborative, partnership relationships and corporate transactions.
查看其它语言版本
新闻
2011年2月14日澳洲股市报告包括：Black Fire Minerals (ASX:BFE)将收购美国内华达州已开发的Pilot Mountain钨-铜项目的100%股份；Virax Holdings Limited (ASX:VHL)将开发一种皮肤癌新药；Southern Cross Goldfields Limited (ASX:SXG)在西澳发现近地表高品位金矿；Prosperity Resources Limited (ASX:PSP)在印尼开始钻探。
###
133,990 公司背景浏览
- 本页浏览人次: (过去7日: 15) (过去30日: 48) (自发布以来: 11736)
